See also this year's filing and all EDGAR filings for this company.
PDF Report 0001586105_2017_Zyla_Life_Sciences.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001586105')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001586105, Zyla Life Sciences
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 93,172,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 8,350,000 |
| 2 | PropertyPlantAndEquipmentNet | 12,709,000 |
| 3 | remainder_Assets | 627,000 |
| 4 | LiabilitiesCurrent | 24,895,000 |
| 5 | LiabilitiesNoncurrent | 84,602,000 |
| 6 | remainder_Liabilities | 35,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,670,000 |
| 9 | ResearchAndDevelopmentExpense | 33,759,000 |
| 10 | remainder_Expenses | 32,497,000 |
| 11 | remainder_Revenues | 16,964,000 |
| 12 | remainder_NetIncome | -10,670,000 |
| 13 | remainder_ComprehensiveNetIncome | 141,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 114,858,000 |
| 1 | Liabilities | 109,532,000 |
| 2 | Expenses | 96,926,000 |
| 3 | Revenues | 16,964,000 |
| 4 | StockholdersEquity | 5,326,000 |
| 5 | NetIncome | -90,632,000 |
| 6 | ComprehensiveNetIncome | -90,561,500 |
| 7 | BaseVar | 174,545,500 |
| 8 | EconomicCapitalRatio | -0.726 |
Edgar->Model Mapping
Feature Distribution
